-
Botanical And Plant Derived Drugs Market Is Booming Worldwide 2024-2031 | GlaxoSmithKline, Pfizer, Inc. Sanofi
29 Mar 2024 07:42 GMT
… Top Companies Analysis :
◘ Bayer Healthcare
◘ GlaxoSmithKline
◘ Pfizer Inc. Sanofi
◘ Actelion Pharmaceuticals …
-
Allergic Bronchopulmonary Aspergillosis Market Forecast 2032: Epidemiology, Clinical Trial, FDA Approval by DelveInsight
28 Mar 2024 12:30 GMT
… , Sanofi, Pulmatrix, Cipla, Novartis, Zambon, GlaxoSmithKline and others.
ALBANY, NEW YORK …
• Sanofi
• Pulmatrix
• Cipla
• Novartis
• Zambon
• GlaxoSmithKline
• And Others.
Download a free …
-
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study
26 Mar 2024 15:45 GMT
… AstraZeneca, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Guidotti, Menarini, Novartis, … AlfaSigma, AstraZeneca, Chiesi, GlaxoSmithKline, Guidotti-Malesci, Menarini, … Biofutura, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Menarini Group, Mundipharma, …
-
Hepatocellular Carcinoma Market to Register Incremental Growth During the Forecast Period (2023-2032) | DelveInsight
26 Mar 2024 15:45 GMT
… & Co., Inc., Pfizer Inc., GlaxoSmith Kline, Celgene Corporation, Teva Pharmaceutical Industries … & Co., Inc., Pfizer Inc., GlaxoSmith Kline, Celgene Corporation, Teva Pharmaceutical Industries …
-
QbD Approach to Small-Scale Studies to Enable Rapid Spray Drying Scale-Up
25 Mar 2024 18:06 GMT
… was a Scientific Leader at Glaxo SmithKline (GSK) for 13 years. Previously …
-
Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
29 Mar 2024 06:30 GMT
… , Arrys Therapeutics, CStone Pharmaceuticals, Deciphera, GlaxoSmithKline, Inhibrx, Innate Pharma, Kiromic, Mersana … ), Pfizer, ImmunoMet, Black Diamond Therapeutics, GlaxoSmithKline, QED Therapeutics, AstraZeneca, EMD Serono …
-
Respiratory Syncytial Virus Market Set to Surge, Reaching US$ 8,137.2 Million by 2032 | Astute Analytica
29 Mar 2024 06:30 GMT
… Roche AG
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Johnson & Johnson…
-
Biochemists discover first new antibacterial class in decades
28 Mar 2024 21:06 GMT
… at the global biopharma company GlaxoSmithKline, are being submitted to the …
-
The Francis Scott Key bridge collapses, and Baltimore’s heart breaks
28 Mar 2024 20:48 GMT
… : As The Post reported, a GlaxoSmithKline inhaler that costs $26 in …
-
How corporate PAC money could end up in the personal coffers of Sens. JD Vance and Markwayne Mullin
28 Mar 2024 20:46 GMT
… PACs, including ConocoPhillips, ExxonMobile, and GlaxoSmithKline.
The optics of accepting the …